Want to create an interactive transcript for this episode?
Podcast: The Mike Hosking Breakfast
Episode: Heather Verry: Diabetes New Zealand CEO on the funding of wearable glucose monitors
Description: Thousands of cases of amputation and vision loss could be prevented thanks to diabetes monitoring technology. Continuous Glucose Monitors, or CGMs, have been funded for Type 1 diabetes since last October. New data from CGM producer Dexcom finds lifetime use of the devices could prevent up to 70 thousand diabetes-related complications and save the country $50 thousand a day. Diabetes New Zealand Chief Executive Heather Verry told Mike Hosking funding should be expanded to all diabetes patients. She says Pharmac is only funding for Type 1, and at $200 a month, these devices are unaffordable for ever...